189 related articles for article (PubMed ID: 27653309)
1. Amplification and protein overexpression of cyclin D1: Predictor of occult nodal metastasis in early oral cancer.
Noorlag R; Boeve K; Witjes MJ; Koole R; Peeters TL; Schuuring E; Willems SM; van Es RJ
Head Neck; 2017 Feb; 39(2):326-333. PubMed ID: 27653309
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic value of 11q13 amplification and protein expression in the detection of nodal metastasis from oral squamous cell carcinoma: a systematic review and meta-analysis.
Noorlag R; van Kempen PM; Stegeman I; Koole R; van Es RJ; Willems SM
Virchows Arch; 2015 Apr; 466(4):363-73. PubMed ID: 25663615
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 amplification in tongue and cheek squamous cell carcinoma.
Mahdey HM; Ramanathan A; Ismail SM; Abraham MT; Jamaluddin M; Zain RB
Asian Pac J Cancer Prev; 2011; 12(9):2199-204. PubMed ID: 22296356
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM Stage I and II squamous cell carcinoma of the oral cavity.
Myo K; Uzawa N; Miyamoto R; Sonoda I; Yuki Y; Amagasa T
Cancer; 2005 Dec; 104(12):2709-16. PubMed ID: 16265665
[TBL] [Abstract][Full Text] [Related]
5. Detection of copy number amplification of cyclin D1 (CCND1) and cortactin (CTTN) in oral carcinoma and oral brushed samples from areca chewers.
Liu HS; Lu HH; Lui MT; Yu EH; Shen W; Chen YP; Chang KW; Tu HF
Oral Oncol; 2009 Dec; 45(12):1032-6. PubMed ID: 19666237
[TBL] [Abstract][Full Text] [Related]
6. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomas.
Miyamoto R; Uzawa N; Nagaoka S; Hirata Y; Amagasa T
Oral Oncol; 2003 Sep; 39(6):610-8. PubMed ID: 12798405
[TBL] [Abstract][Full Text] [Related]
8. Tumour thickness as a predictor of nodal metastases in oral cancer: comparison between tongue and floor of mouth subsites.
Balasubramanian D; Ebrahimi A; Gupta R; Gao K; Elliott M; Palme CE; Clark JR
Oral Oncol; 2014 Dec; 50(12):1165-8. PubMed ID: 25307875
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.
Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA
Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340
[TBL] [Abstract][Full Text] [Related]
10. Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies.
Miyamoto R; Uzawa N; Nagaoka S; Nakakuki K; Hirata Y; Amagasa T
Cancer; 2002 Nov; 95(10):2152-9. PubMed ID: 12412169
[TBL] [Abstract][Full Text] [Related]
11. Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
Lundgren K; Holm K; Nordenskjöld B; Borg A; Landberg G
Breast Cancer Res; 2008; 10(5):R81. PubMed ID: 18823530
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization for detecting genomic alterations of cyclin D1 and p16 in oral squamous cell carcinomas.
Uzawa N; Sonoda I; Myo K; Takahashi K; Miyamoto R; Amagasa T
Cancer; 2007 Nov; 110(10):2230-9. PubMed ID: 17893905
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 expression in oral squamous cell carcinomas: clinicopathological relevance and correlation with p53 expression.
Lam KY; Ng IO; Yuen AP; Kwong DL; Wei W
J Oral Pathol Med; 2000 Apr; 29(4):167-72. PubMed ID: 10766394
[TBL] [Abstract][Full Text] [Related]
15. Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study.
Dedes KJ; Lopez-Garcia MA; Geyer FC; Lambros MB; Savage K; Vatcheva R; Wilkerson P; Wetterskog D; Lacroix-Triki M; Natrajan R; Reis-Filho JS
Breast Cancer Res Treat; 2010 Dec; 124(3):653-66. PubMed ID: 20213079
[TBL] [Abstract][Full Text] [Related]
16. An update on the implications of cyclin D1 in oral carcinogenesis.
Ramos-García P; Gil-Montoya JA; Scully C; Ayén A; González-Ruiz L; Navarro-Triviño FJ; González-Moles MA
Oral Dis; 2017 Oct; 23(7):897-912. PubMed ID: 27973759
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes.
Capaccio P; Pruneri G; Carboni N; Pagliari AV; Quatela M; Cesana BM; Pignataro L
Head Neck; 2000 May; 22(3):234-40. PubMed ID: 10748446
[TBL] [Abstract][Full Text] [Related]
18. Cortactin is a prognostic marker for oral squamous cell carcinoma and its overexpression is involved in oral carcinogenesis.
Liu YC; Ho HC; Lee MR; Yeh CM; Tseng HC; Lin YC; Chung JG
Environ Toxicol; 2017 Mar; 32(3):799-812. PubMed ID: 27148699
[TBL] [Abstract][Full Text] [Related]
19. Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.
Liu SC; Zhang SY; Babb JS; Ridge JA; Klein-Szanto AJ
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):455-9. PubMed ID: 11352854
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 amplification correlates with early recurrence of squamous cell carcinoma of the tongue.
Fujii M; Ishiguro R; Yamashita T; Tashiro M
Cancer Lett; 2001 Oct; 172(2):187-92. PubMed ID: 11566495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
